Karyopharm Therapeutics, a pharmaceutical company specializing in novel cancer therapies, announced that its senior management will participate in two investor conferences on May 19, 2026: the H.C. Wainwright 4th Annual BioConnect and the RBC 2026 Global Healthcare Conference. Both events will feature fireside chats and will be webcast live on the company's website. This participation highlights Karyopharm's ongoing efforts to engage with investors and showcase its progress with its lead cancer drug, XPOVIO (selinexor), which is approved in multiple countries. Investors can access the presentations online and replay them after the events.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) surged past the $1,894.89 resistance level, accelerating its recovery toward the $1,940–$1,950 zone after days of consolidation. This breakout was supported by lower-than-expected U.S. inflation data, which boosted risk appetite and bu...
Allied Critical Metals announced positive assay results from its 2026 drilling campaign at the Santa Helena Breccia, part of the Borralha Tungsten Project in Portugal. The first drill hole confirmed broad zones of high-grade tungsten mineralization, ...
Ethereum's price rose about 11% over the past week to around $1,920, outperforming major cryptocurrencies like Bitcoin and Solana. This rally is fueled by $96 million inflows into U.S. spot Ether ETFs early in the week, with BlackRock's ETHA product ...
The XRP Ledger has surpassed 8 million activated accounts, marking steady growth since March 2026. However, daily active addresses have declined to a 2026 low of 25,350, indicating less frequent user engagement despite overall adoption. XRP's price f...
